10 replies to this topic

[ryukenden]

I am thinking of buyinf some shares.

Is Chromadex the only seller of Nicontinamide Riboside? Have any of you bought any of its shares?

Many thanks

[Supierce]

It looks like Proctor and Gamble intends to compete with them:

 

https://www.google.c...s/US20170121746

 

Edited by Supierce, 18 July 2017 - 01:07 PM.

[stefan_001]

I bought 0.15% in the past 12 months

[ryukenden]

I bought 0.15% in the past 12 months

How many shares in 0.15%?

[stefan_001]

 

I bought 0.15% in the past 12 months

How many shares in 0.15%?

 

 

as investor I am sure you can calculate it. Anyways I think it is a high risk stock, I would not recommend it to family or friends.

[Bryan_S]

PTO Litigation Report – July 18, 2017

 

Trial Number – IPR2017-01795

Filing Date – 7/17/2017

Patent # – 8,383,086

Title – NICOTINAMIDE RIBOSIDE KINASE COMPOSITIONS AND METHODS FOR USING THE SAME

Patent Owner –  TRUSTEES OF DARTMOUTH COLLEGE

Petitioner – ELYSIUM HEALTH, INC.

Tech Center – 1600

Trial Number – IPR2017-01796

Filing Date – 7/17/2017

Patent # – 8,383,086

Title – NICOTINAMIDE RIBOSIDE KINASE COMPOSITIONS AND METHODS FOR USING THE SAME

Patent Owner –  TRUSTEES OF DARTMOUTH COLLEGE

Petitioner – ELYSIUM HEALTH, INC.

Tech Center – 1600

 

https://www.natlawre...rt-july-18-2017

[bluemoon]

PTO Litigation Report – July 18, 2017

 

Trial Number – IPR2017-01795

Filing Date – 7/17/2017

Patent # – 8,383,086

Title – NICOTINAMIDE RIBOSIDE KINASE COMPOSITIONS AND METHODS FOR USING THE SAME

Patent Owner –  TRUSTEES OF DARTMOUTH COLLEGE

Petitioner – ELYSIUM HEALTH, INC.

Tech Center – 1600

Trial Number – IPR2017-01796

Filing Date – 7/17/2017

Patent # – 8,383,086

Title – NICOTINAMIDE RIBOSIDE KINASE COMPOSITIONS AND METHODS FOR USING THE SAME

Patent Owner –  TRUSTEES OF DARTMOUTH COLLEGE

Petitioner – ELYSIUM HEALTH, INC.

Tech Center – 1600

 

https://www.natlawre...rt-july-18-2017

 

 

 

Does anyone know if Elysium has much of a chance here?

[ryukenden]

PTO Litigation Report – July 18, 2017

Trial Number – IPR2017-01795
Filing Date – 7/17/2017
Patent # – 8,383,086
Title – NICOTINAMIDE RIBOSIDE KINASE COMPOSITIONS AND METHODS FOR USING THE SAME
Patent Owner – TRUSTEES OF DARTMOUTH COLLEGE
Petitioner – ELYSIUM HEALTH, INC.
Tech Center – 1600
Trial Number – IPR2017-01796
Filing Date – 7/17/2017
Patent # – 8,383,086
Title – NICOTINAMIDE RIBOSIDE KINASE COMPOSITIONS AND METHODS FOR USING THE SAME
Patent Owner – TRUSTEES OF DARTMOUTH COLLEGE
Petitioner – ELYSIUM HEALTH, INC.
Tech Center – 1600

https://www.natlawre...rt-july-18-2017

Interesting. We have to wait and see the outcome.

Thanks

[bluemoon]

ChromaDex's next shareholder's meeting will be held around August 11th or 12th if recent years are a guide, so it will be interesting to see if their results will be put on their website prior to that or if they will announce a postponement.  

[ryukenden]

ChromaDex's next shareholder's meeting will be held around August 11th or 12th if recent years are a guide, so it will be interesting to see if their results will be put on their website prior to that or if they will announce a postponement.

Thank you. We will wait and see.

[Evan Yang]

The outcome of patent lawsuit may determine if ChromaDex goes to $100 or $1000. But it is irrelevant at $3. First after FDA accepts the IND for Cockayne syndrome, no company can start selling NR other than Niagen which is grand fathered. Secondly, the ChromaDex and Li Ka-Shing (13,000 health stores) partnership will sell Billions of Niagen annually. Since Li Ka-Shing owns 20% of ChromaDex, he will keep selling Niagen even if there is another vendor offering NR at cheaper price. Li Ka-Shing is serious about Niagen so he will promote it in his stores. Not like CVS who just let it sit there without any promotion and people don't know what it is.